Treating cancer patients with T cell-based therapies has shown some some promise in the clinic, but not all patients respond. There could be many reasons for this, some of which might be addressed by using the best possible antitumour T cell. What are the biological properties of such a cell and can we generate one?
- Luca Gattinoni
- Christopher A. Klebanoff
- Nicholas P. Restifo